Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.6.0 to v3.6.3, indicating a small update to the study record metadata on the page. This reflects a minor revision to the page's versioning rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-06-30T01:12:41.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Recruitment status updated to indicate no enrollment; new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment label was standardized, and the revision tag updated to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-15T19:07:55.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.4 to v3.5.5, signaling a small update to the site's revision history.
    Difference
    0.0%
    Check dated 2026-06-08T15:24:58.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 for the study record, indicating a metadata/version change in the COMBAT entry. This update does not modify the study content or eligibility details.
    Difference
    0.0%
    Check dated 2026-05-18T04:15:26.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator has been updated from **Revision: v3.5.0** to **Revision: v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-26T15:39:38.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be an internal version update and does not modify study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-03-21T20:25:32.000Z thumbnail image

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.